These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 33388775

  • 1. Hypoalbuminaemia, Not Biologic Exposure, Is Associated with Postoperative Complications in Crohn's Disease Patients Undergoing Ileocolic Resection.
    Shah RS, Bachour S, Jia X, Holubar SD, Hull TL, Achkar JP, Philpott J, Qazi T, Rieder F, Cohen BL, Regueiro MD, Lightner AL, Click BH.
    J Crohns Colitis; 2021 Jul 05; 15(7):1142-1151. PubMed ID: 33388775
    [Abstract] [Full Text] [Related]

  • 2. Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles?
    Lightner AL, McKenna NP, Alsughayer A, Harmsen WS, Taparra K, Parker ME, Raffals LE, Loftus EV.
    Dis Colon Rectum; 2019 Nov 05; 62(11):1352-1362. PubMed ID: 31567927
    [Abstract] [Full Text] [Related]

  • 3. Postoperative Safety Profile of Minimally Invasive Ileocolonic Resections for Crohn's Disease in the Era of Biologic Therapy.
    Abd El Aziz MA, Abdalla S, Calini G, Saeed H, Stocchi L, Merchea A, Colibaseanu DT, Shawki S, Larson DW.
    J Crohns Colitis; 2022 Aug 04; 16(7):1079-1088. PubMed ID: 35045164
    [Abstract] [Full Text] [Related]

  • 4. Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations.
    Lightner AL, McKenna NP, Tse CS, Raffals LE, Loftus EV, Mathis KL.
    Aliment Pharmacol Ther; 2018 Mar 04; 47(5):573-580. PubMed ID: 29250800
    [Abstract] [Full Text] [Related]

  • 5. Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease.
    Shental O, Tulchinsky H, Greenberg R, Klausner JM, Avital S.
    Dis Colon Rectum; 2012 Nov 04; 55(11):1125-30. PubMed ID: 23044672
    [Abstract] [Full Text] [Related]

  • 6. Determining Predictors for Intra-abdominal Septic Complications Following Ileocolonic Resection for Crohn's Disease-Considerations in Pre-operative and Peri-operative Optimisation Techniques to Improve Outcome.
    Morar PS, Hodgkinson JD, Thalayasingam S, Koysombat K, Purcell M, Hart AL, Warusavitarne J, Faiz O.
    J Crohns Colitis; 2015 Jun 04; 9(6):483-91. PubMed ID: 25796553
    [Abstract] [Full Text] [Related]

  • 7. The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab.
    Kassouri L, Amiot A, Kirchgesner J, Tréton X, Allez M, Bouhnik Y, Beaugerie L, Carbonnel F, Meyer A.
    Dig Liver Dis; 2020 Oct 04; 52(10):1148-1155. PubMed ID: 32828693
    [Abstract] [Full Text] [Related]

  • 8. Nomogram to Predict Postoperative Intra-abdominal Septic Complications After Bowel Resection and Primary Anastomosis for Crohn's Disease.
    Zhu F, Li Y, Guo Z, Cao L, Feng D, Zhang T, Zhu W, Gong J.
    Dis Colon Rectum; 2020 May 04; 63(5):629-638. PubMed ID: 32032204
    [Abstract] [Full Text] [Related]

  • 9. Preoperative Anti-TNF Therapy is Associated with a Shorter Length of Resected Bowel in Patients Undergoing Ileocolic Resection for Crohn's Disease.
    Huang Y, Yao D, Guo F, Zhou Z, Li Y.
    J Invest Surg; 2022 Jun 04; 35(6):1357-1365. PubMed ID: 34983280
    [Abstract] [Full Text] [Related]

  • 10. Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients.
    Lightner AL, McKenna NP, Alsughayer A, Loftus EV, Raffals LE, Faubion WA, Moir C.
    J Pediatr Surg; 2019 Oct 04; 54(10):2162-2165. PubMed ID: 30773391
    [Abstract] [Full Text] [Related]

  • 11. Postoperative Morbidity Risks Following Ileocolic Resection for Crohn's Disease Treated With Anti-TNF Alpha Therapy: A Retrospective Study of 360 Patients.
    Jouvin I, Lefevre JH, Creavin B, Pitel S, Chafai N, Tiret E, Beaugerie L, Parc Y, Saint-Antoine IBD Network.
    Inflamm Bowel Dis; 2018 Jan 18; 24(2):422-432. PubMed ID: 29361093
    [Abstract] [Full Text] [Related]

  • 12. High complication rate in Crohn's disease surgery following percutaneous drainage of intra-abdominal abscess: a multicentre study.
    Celentano V, Giglio MC, Pellino G, Rottoli M, Sampietro G, Spinelli A, Selvaggi F, Italian Society of Colorectal Surgery SICCR.
    Int J Colorectal Dis; 2022 Jun 18; 37(6):1421-1428. PubMed ID: 35599268
    [Abstract] [Full Text] [Related]

  • 13. Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's disease.
    Townsend T, Razanskaite V, Dodd S, Storey D, Michail S, Morgan J, Davies M, Penman D, Watters C, Swaminathan M, Sabine J, Chapman A, Smith PJ, Flanagan PK, Reilly I, Bodger K, Subramanian S.
    Aliment Pharmacol Ther; 2020 Oct 18; 52(8):1341-1352. PubMed ID: 32955122
    [Abstract] [Full Text] [Related]

  • 14. Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection.
    Axelrad JE, Li T, Bachour SP, Nakamura TI, Shah R, Sachs MC, Chang S, Hudesman DP, Holubar SD, Lightner AL, Barnes EL, Cohen BL, Rieder F, Esen E, Remzi F, Regueiro M, Click B.
    Inflamm Bowel Dis; 2023 Jun 01; 29(6):888-897. PubMed ID: 35905032
    [Abstract] [Full Text] [Related]

  • 15. Mesenteric Excision and Exclusion for Ileocolic Crohn's Disease: Feasibility and Safety of an Innovative, Combined Surgical Approach With Extended Mesenteric Excision and Kono-S Anastomosis.
    Holubar SD, Gunter RL, Click BH, Achkar JP, Lightner AL, Lipman JM, Hull TL, Regueiro M, Rieder F, Steele SR.
    Dis Colon Rectum; 2022 Jan 01; 65(1):e5-e13. PubMed ID: 34882636
    [Abstract] [Full Text] [Related]

  • 16. Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease.
    Lightner AL, McKenna NP, Tse CS, Hyman N, Smith R, Ovsepyan G, Fleshner P, Crowell K, Koltun W, Ferrante M, D'Hoore A, Lauwers N, Verstockt B, Spinelli A, DiCandido F, Raffals LE, Mathis KL, Loftus EV.
    J Crohns Colitis; 2018 Mar 28; 12(4):402-407. PubMed ID: 29220430
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study.
    Yamamoto T, Spinelli A, Suzuki Y, Saad-Hossne R, Teixeira FV, de Albuquerque IC, da Silva RN, de Barcelos IF, Takeuchi K, Yamada A, Shimoyama T, da Silva Kotze LM, Sacchi M, Danese S, Kotze PG.
    United European Gastroenterol J; 2016 Dec 28; 4(6):784-793. PubMed ID: 28408996
    [Abstract] [Full Text] [Related]

  • 19. Intra-abdominal septic complications after ileocolic resection increases risk for endoscopic and surgical postoperative Crohn's disease recurrence.
    Bachour SP, Shah RS, Rieder F, Qazi T, Achkar JP, Philpott J, Lashner B, Holubar SD, Lightner AL, Barnes EL, Axelrad J, Regueiro M, Click B, Cohen BL.
    J Crohns Colitis; 2022 Nov 23; 16(11):1696-1705. PubMed ID: 35705188
    [Abstract] [Full Text] [Related]

  • 20. Are Biologics Safe in the Immediate Postoperative Period? A Single-Center Evaluation of Consecutive Crohn's Surgical Patients.
    Lightner AL, Grass F, Alsughayer AM, Harmsen WS, Petersen M, Loftus EV.
    Dis Colon Rectum; 2020 Jul 23; 63(7):934-943. PubMed ID: 32149787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.